Written by Tahir Amin
-
The Folly of Hoarding Knowledge in the COVID-19 Age
Let Vaccine Producers in Poor Countries Help End the Pandemic (Foreign Affairs, January 2021)
-
Innovation alone won’t end COVID-19
(Nature, January 2022)
-
A Global Intellectual Property Waiver is Still Needed to Address the Inequities of Covid-19 and Future Pandemic Preparedness
(Sage Journals, September 2022)
-
Think "Squid Game" is Scary? Our Real Life Vaccine Inequity is Worse
(Medium, October 2021)
-
Big Pharma's Patent Abuses are Fueling the Drug Pricing Crisis
(TIME, February 2023)
-
TrumpRx and a most favored nation policy won’t lower prices for patients
(STAT, October 2025)
-
At the Mercy of Big Pharma
A new book explains why drugs cost so much in the United States — and why Trump’s claims about addressing the crisis are bogus (May 2026)
-
Canada and India now have generic Wegovy. Here’s why the U.S. doesn’t.
(MarketWatch, May 2026)
-
‘Free markets’ and shackled access to medicines
(The Hindu Businessline, May 2026)
Podcast Interviews & Features with Tahir
-
New York Times - The Argument
Could Spilling Big Pharma’s Secrets Vaccinate the World?
-
Pitchfork Economics with Nick Hanauer
Vaccine development needs new incentives
-
Radical x Change(s)
On a More Just and Equitable Approach to Intellectual Property
-
Forbes
Interview/book feature